What is the recommended medication regimen for streptococcal pharyngitis, including adult and pediatric dosing and alternatives for patients with penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Strep Throat Medication

For adults and children, amoxicillin 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for a full 10 days is the first-line treatment for streptococcal pharyngitis. 1, 2

First-Line Therapy for Non-Allergic Patients

  • Amoxicillin is preferred over penicillin V because of superior palatability in children, convenient once- or twice-daily dosing that improves adherence, and identical efficacy against Group A Streptococcus. 1, 3
  • Adult dosing: 500 mg orally twice daily for 10 days, or 1000 mg once daily for 10 days. 1, 2
  • Pediatric dosing: 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days. 1, 2
  • Zero documented penicillin resistance exists worldwide among Group A Streptococcus, guaranteeing reliable bacterial eradication. 1, 3
  • Penicillin V remains an acceptable alternative at 500 mg twice daily (adults) or 250 mg twice daily (children <27 kg) for 10 days, though amoxicillin is generally preferred. 3

Mandatory 10-Day Duration

  • A complete 10-day course is absolutely required to achieve maximal pharyngeal eradication and prevent acute rheumatic fever, even when symptoms resolve within 3–4 days. 1, 3, 2
  • Shortening the course by even 2–3 days markedly increases treatment failure rates and rheumatic fever risk. 1, 3
  • The primary goal is preventing acute rheumatic fever and suppurative complications through complete bacterial eradication, not merely symptom relief. 1, 4

Treatment for Penicillin-Allergic Patients

Non-Immediate (Delayed) Penicillin Allergy

  • First-generation cephalosporins are the preferred alternatives with strong, high-quality evidence and only 0.1% cross-reactivity risk in delayed reactions. 1, 5, 3
  • Cephalexin: 500 mg twice daily for 10 days (adults); 20 mg/kg twice daily (maximum 500 mg per dose) for 10 days (children). 1, 5, 6
  • Cefadroxil: 1 gram once daily for 10 days (adults); 30 mg/kg once daily (maximum 1 gram) for 10 days (children). 1, 5

Immediate/Anaphylactic Penicillin Allergy

  • All β-lactam antibiotics must be avoided because cross-reactivity reaches approximately 10% in patients with immediate hypersensitivity (anaphylaxis, angioedema, urticaria within 1 hour). 1, 5, 3

  • Clindamycin is the preferred non-β-lactam alternative with only ~1% resistance among U.S. Group A Streptococcus isolates and superior eradication even in chronic carriers. 1, 5, 3

    • Adult dosing: 300 mg orally three times daily for 10 days. 1, 5
    • Pediatric dosing: 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days. 1, 5
  • Azithromycin is an acceptable alternative but less preferred due to 5–8% macrolide resistance in the United States. 1, 5, 3

    • Adult dosing: 500 mg once daily for 5 days. 1, 5
    • Pediatric dosing: 12 mg/kg once daily (maximum 500 mg) for 5 days. 1, 5
    • Azithromycin is the only antibiotic requiring just 5 days due to its prolonged tissue half-life. 1, 5
  • Clarithromycin is another macrolide option with similar resistance concerns as azithromycin. 1, 5

    • Adult dosing: 250 mg twice daily for 10 days. 1, 5
    • Pediatric dosing: 7.5 mg/kg twice daily (maximum 250 mg per dose) for 10 days. 1, 5

Critical Pitfalls to Avoid

  • Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to the ~10% cross-reactivity risk. 1, 5, 3
  • Do not shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen), as this dramatically increases treatment failure and rheumatic fever risk. 1, 3
  • Do not prescribe trimethoprim-sulfamethoxazole (Bactrim) for strep throat; it fails to eradicate Group A Streptococcus in 20–25% of cases. 1, 5
  • Do not use tetracyclines or fluoroquinolones for streptococcal pharyngitis due to high resistance rates and unnecessary broad-spectrum activity. 1, 3
  • Do not order routine post-treatment throat cultures for asymptomatic patients who completed therapy; reserve testing for special circumstances such as history of rheumatic fever. 1, 3

Adjunctive Symptomatic Management

  • Offer acetaminophen or ibuprofen for moderate-to-severe sore throat, fever, or systemic discomfort. 1, 3
  • Avoid aspirin in children because of the risk of Reye syndrome. 1, 3
  • Corticosteroids are not recommended as adjunctive therapy for streptococcal pharyngitis. 1, 3

Intramuscular Option for Adherence Concerns

  • Benzathine penicillin G as a single intramuscular injection ensures compliance when oral adherence is uncertain. 3, 7
    • Dosing <27 kg: 600,000 units IM once. 3
    • Dosing ≥27 kg: 1.2 million units IM once. 3

Management of Treatment Failure

  • If symptoms persist after a fully adhered 10-day course, switch to clindamycin (300 mg three times daily for 10 days in adults; 7 mg/kg three times daily for 10 days in children) to achieve higher eradication rates, especially in chronic carriers. 1, 3
  • Amoxicillin-clavulanate (40 mg amoxicillin/kg/day divided three times daily, maximum 2000 mg amoxicillin/day, for 10 days) is substantially more effective than plain amoxicillin in chronic carriers or treatment failures. 1

References

Guideline

Oral Amoxicillin as First‑Line Therapy for Pediatric Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Treatment for Suspected Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.